 MBS Introduces New Clones to Staph Aureus
MBS is pleased to introduce four new monoclonal antibodies to Staph Aureus enterotoxin A and four clones to Staph Aureus enterotoxin B. These high affinity clones have been well characterized and demonstrate matched pair ability. The antibodies will be out of production phase and available soon. Please click below or contact our Sales Representatives at 1-800-925-9476 for more information.
|
MBS Introduces New Clones to Osteopontin
MBS has developed five clones to Osteopontin. Four of the clones recognize the N terminal end and one of the clones recognizes the C terminal end of full length Osteopontin. These highly pure, well characterized clones are soon to be published in BCM. Look for the following reference in an upcoming issue:
Development of Fragment Specific Osteopontin Antibodies and ELISA for Quantification in Human Metastatic Breast Cancer. Alicia Plumer, Hongyi Duan, Sripriya Subramaniam, F. Lee Lucas, Susan Meisfeldt, Ah-Kau Ng, Lucy Liaw
|
|
Sales Director Focusing on the West Coast
MBS Sales Director, Carrie Cloutier, will spend a number of months focusing on expanding business opportunities on the West Coast. Carrie will be working from San Diego and making customer visits all over the region. Carrie's day to day function for MBS will remain the same and she remains as accessable to customers as always by her phone extension,14. Sales Representatives, Adam Curtis and Abby Culberson can be reached at 1-800-925-9476 in the office. |
